Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?

PURPOSE: The aims of this study were to develop a prostate-specific membrane antigen (PSMA) ligand for labelling with different radioisotopes of lead and to obtain an approximation of the dosimetry of a simulated (212)Pb-based alpha therapy using its (203)Pb imaging analogue. METHODS: Four novel Glu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Nucl Med Mol Imaging
Main Authors: dos Santos, José Carlos, Schäfer, Martin, Bauder-Wüst, Ulrike, Lehnert, Wencke, Leotta, Karin, Morgenstern, Alfred, Kopka, Klaus, Haberkorn, Uwe, Mier, Walter, Kratochwil, Clemens
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451745/
https://ncbi.nlm.nih.gov/pubmed/30603987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4220-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki